亚盛医药上半年亏损同比扩大至8.17亿元

财中社
Aug 20

8月20日,亚盛医药(06855)发布截至2026年6月30日止6个月的未经审计综合业绩。报告期内,公司收益为3.02亿元,按固定汇率计算,同比增长29.3%;归母净亏损为8.17亿元,而去年同期亏损5.91亿元。  2026年上半年,公司的行政开支达1.19亿元,同比增长19.3%,主要是由于购股权及受限制股份单位开支增加所致。公司的其他开支主要包括慈善捐款、汇兑亏损和资产减值亏损。2026年...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10